Hello and welcome to the annual meeting of stockholders of Solid Biosciences Inc. It is now my pleasure to turn today's meeting over to Bo Cumbo, President, Chief Executive Officer, and a member of the Board of Directors of Solid Biosciences. Mr. Cumbo, the floor is yours. Thank you. Good morning, welcome to the 2026 annual meeting of stockholders of Solid Biosciences. I am Bo Cumbo, President, Chief Executive Officer, and a member of the Board of Directors of Solid Biosciences, I will be presiding over this meeting. I welcome you to this live webcast call the meeting to order. While the meeting is virtual only, we have designed this meeting to provide stockholders the same rights and opportunities to participate as they would at an in-person meeting, we welcome questions from our stockholders. We will address stockholder questions regarding the proposals before our stockholders prior to the closing of the polls. You may vote your shares online at any time during the meeting prior to the closing of the polls. Before we get to the formal business of the meeting, I would like to make some introductions. Joining us virtually at the meeting today are the following board members: Ian Smith, Marty Freed, Ilan Ganot, Clare Kahn, Georgia Keresty, Suku Nagendran, Adam Stone, Lynne Sullivan. Also from Solid Biosciences, Kim Cornwell, our General Counsel and Corporate Secretary, who will also serve as moderator for today's meeting. Kevin Tan, our Chief Financial Officer. Ty Howton, our Chief Operating Officer. I would also like to introduce Rhonda Carroll, a representative from Governance Resources LLC, who has been appointed to act as Inspector of Election. Dave Cawley, a representative from PricewaterhouseCoopers, our independent registered public accounting firm, Caroline DiTullo from WilmerHale, our Corporate Counsel. I will now turn the meeting over to Kim Cornwell, our General Counsel and Corporate Secretary, to conduct the formal part of the meeting. Thank you, Bo. In order to conduct an orderly meeting, I call your attention to the rules of conduct posted on the virtual meeting website, which include information about participating in the meeting, including asking questions. Please note that various remarks that we may make about future expectations, plans, and prospects for the company constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of our most recent quarterly report on Form 10-Q, which is on file with the SEC. In addition, these forward-looking statements represent the company's expectations only as of today, June 10th, 2026. While the company may elect to update these forward-looking statements, it specifically disclaims any obligation to do so. Any forward-looking statements should not be relied upon as representing the company's estimates or views as of any date subsequent to today. I have received an affidavit from Broadridge certifying that the notice of annual meeting and proxy statement were sent to all stockholders of record as of April 16th, 2026, a copy of which will be included in the minutes of the meeting. Our first order of business is to determine whether the shares represented at this meeting, either in person, via this virtual meeting, or by proxy, are sufficient to constitute a quorum for the purposes of transacting business. Holders of 94,413,277 shares of common stock are entitled to vote at this meeting. The Inspector of Elections has informed me that there are present at this meeting, either in person or by proxy, a total of 85,206,154 shares of common stock, or approximately 86.57% of all shares entitled to vote at this meeting. Therefore, I declare that a quorum exists. Turning now to the items to be voted on at this meeting, as indicated in the notice of meeting and accompanying documents that were made available to stockholders. The first matter to be voted on is the election of three Class II directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified. The three nominees for election are Clare Kahn, Adam Stone, Lynne Sullivan. The second matter to be voted on is ratification of the appointment of Ilan Ganot on an advisory basis to our board of directors as a Class I director to hold office until the 2028 annual meeting of stockholders and until his successor has been elected and qualified. The third matter to be voted on is the ratification of the selection of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the current fiscal year. The fourth matter to be voted on is the approval of an amendment to our certificate of incorporation as amended, for our certificate of incorporation to increase the number of authorized shares of our common stock from 240 million- 480 million. The fifth and final matter to be voted on is the approval of an advisory vote on executive compensation. The proxy statement for this meeting contained the text of the resolution that stockholders are asked to approve. If there are any questions on the proposals, they may be submitted on the virtual meeting website. If asking a question, please also include your name and affiliation to the company. Moderator, do we have any questions at this time? Seeing no questions, we'll move on to voting on the proposals. Okay, I hereby declare that the polls are now open for each matter to be voted upon today. Stockholders who have previously voted by proxy need not take any further action with respect to any of the matters to be voted on today. If you have not yet voted, or if you previously voted by proxy and wish to change your vote, you may vote by clicking on the voting button on the virtual meeting website and follow the instructions there. We will pause briefly to allow stockholders to vote. We now have the preliminary report of the results of the meeting. Each of the nominees for director has been elected as a class two director. The ratification of the appointment of Ilan Ganot on an advisory basis as a class one director has passed. The appointment of PricewaterhouseCoopers has been ratified. The amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 240 million- 480 million has been approved. The advisory vote on executive compensation has passed. The final vote results will be included in the Form 8-K that will be filed within four business days following this meeting. As there is no further business to come before this meeting, I declare the formal part of this meeting adjourned. The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.